Carbylan achieves positive COR1.0 clinical trial results
Carbylan BioSurgery, a developer of device/drug combination products, has released Hydros-TA joint therapy (Hydros-TA) and Hydros positive COR1.0…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Jul 11
Carbylan BioSurgery, a developer of device/drug combination products, has released Hydros-TA joint therapy (Hydros-TA) and Hydros positive COR1.0…
26 Jul 11
GE Healthcare has launched computed tomography (CT) image reconstruction technology 'Veo' in Canada.
26 Jul 11
Illinois Bone and Joint Institute (IBJI) has installed High Field Open MRI to serve patients of Chicago and…
26 Jul 11
CareFusion has entered into a five-year agreement to distribute ResMed Stellar 100 and 150 non-invasive ventilators (NIV) and…
26 Jul 11
Zotec Partners has received ambulatory meaningful use certification by the certified HIT product list (CHPL) under the EHR…
26 Jul 11
Waters has received CE mark approval for its MassTrak Immunosuppressants XE Kit which assesses concentrations of the parent…
26 Jul 11
Medtronic has compared its Resolute drug-eluting stent (DES) with Boston Scientific's Taxus DES which showed superiority in the…
25 Jul 11
National Health Laboratory Services (NHLS) of South Africa has awarded Roche Diagnostics a contract to support the Early…
25 Jul 11
The Christie Foundation Trust at Salford Royal, England has installed Novalis system at its radiotherapy centre to treat…
25 Jul 11
Australian Therapeutic Goods Administration (TGA) has approved 12 months of treatment for its EndoBarrier Gastrointestinal Liner (the EndoBarrier)…